Tadalafil has No Detrimental Effect on Human Spermatogenesis or Reproductive Hormones-Reference-Cited by-同舟云学术

Tadalafil has No Detrimental Effect on Human Spermatogenesis or Reproductive Hormones

Published:2003-09 Issue:3 Volume:170 Page:887-891
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

HELLSTROM WAYNE J.G.¹,OVERSTREET JAMES W.¹,YU ALBERT¹,SAIKALI KHALIL¹,SHEN WEI¹,BEASLEY CHARLES M.¹,WATKINS VISH S.¹

Affiliation:

1. From the Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana, Department of Obstetrics and Gynecology, University of California-Davis, Davis, California, ICOS Corp., Bothell, Washington, and Eli Lilly and Co., Indianapolis, Indiana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Efficacy and safety of tadalafil in the treatment of erectile dysfunction: results of integrated analyses;Brock;J Urol,2002

2. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A;Fawcett;Proc Natl Acad Sci USA,2000

3. Phosphodiesterase type 11 (PDE11) cellular localisation: progress towards defining a physiological role in testis and/or reproduction;Baxendale;J Urol,2001

4. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction,1987

5. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction,1999

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alchornea cordifolia and Lecaniodiscus cupanioides supplemented diets abate sexual dysfunction and modulate altered biochemical indexes in the corpus cavernosum of scopolamine-administered rats;Comparative Clinical Pathology;2024-06-15

2. Medications With Male Reproductive Side Effects;Reference Module in Biomedical Sciences;2024

3. Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments;Expert Opinion on Investigational Drugs;2023-07-03

4. Oral phosphodiesterase type 5 inhibitors and male reproductive potential: an overview;Sexual Medicine Reviews;2023-03-29

5. The efficacy of PDE5 inhibitors in diabetic patients;Andrology;2022-12-09